GPX1 and metabolic dysfunction-associated steatohepatitis: Our own studies have shown that the deletion of Gpx1 in hepatocytes and the resultant increased H2O2 levels enhanced insulin sensitivity in HFD-fed mice and attenuated NASH and fibrosis in mice fed a choline-deficient, amino acid–defined (CDAA) diet (67).